Literature DB >> 32766

Mechanisms of action of cholera and Escherichia coli enterotoxins.

M Field.   

Abstract

Current information is reviewed on the mechanism of secretion in small intestine, including how it is altered by cyclic 3',5'-adenosine monophosphate and on the structures and properties of cholera and both heat-labile and heat-stable Escherichia coli enterotoxins. Two separate active ion transport processes are altered by cyclic 3',5'-adenosine monophosphate: 1) coupled absorption of NaCl is inhibited in villus cells and 2) active anion secretion is stimulated, probably in crypt cells. Cholera and heat-labile E. coli toxins exert their secretory effect by stimulating intestinal mucosal adenylate cyclase. This stimulation results from the A1 subunit catalyzed transfer of adenosine diphosphate ribose from NAD to a membrane-bound guanosine triphosphatase, thereby inhibiting the enzyme, which normally represses adenylate cyclase. Heat-stable E. coli enterotoxin stimulates intestinal mucosal guanylate cyclase, which appears to be the basis for its enterotoxicity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 32766     DOI: 10.1093/ajcn/32.1.189

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  27 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

Review 2.  Molecular staging individualizing cancer management.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  J Surg Oncol       Date:  2012-04-01       Impact factor: 3.454

Review 3.  GUCY2C molecular staging personalizes colorectal cancer patient management.

Authors:  Jian P Gong; Stephanie Schulz; Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2012-06       Impact factor: 2.851

4.  Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases.

Authors:  Sujin Lee; Puay-Wah Phuan; Christian M Felix; Joseph-Anthony Tan; Marc H Levin; Alan S Verkman
Journal:  J Med Chem       Date:  2017-01-31       Impact factor: 7.446

5.  Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.

Authors:  F C Knoop; D D Thomas
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins.

Authors:  Onur Cil; Puay-Wah Phuan; Anne Marie Gillespie; Sujin Lee; Lukmanee Tradtrantip; Jianyi Yin; Ming Tse; Nicholas C Zachos; Ruxian Lin; Mark Donowitz; Alan S Verkman
Journal:  FASEB J       Date:  2016-11-08       Impact factor: 5.191

7.  Protein phosphorylation by protein kinase C in HEp-2 cells infected with enteropathogenic Escherichia coli.

Authors:  T J Baldwin; S F Brooks; S Knutton; H A Manjarrez Hernandez; A Aitken; P H Williams
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

8.  IgA antibodies in rat bile inhibit cholera toxin-induced secretion in ileal loops in situ.

Authors:  T Tamaru; W R Brown
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

Review 9.  CFTR inhibitors.

Authors:  Alan S Verkman; David Synder; Lukmanee Tradtrantip; Jay R Thiagarajah; Marc O Anderson
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Prostaglandins are not mediators of the intestinal response to cholera toxin.

Authors:  G S Smith; G Warhurst; A Tonge; L A Turnberg
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.